Mid-Florida Hematology & Oncology Centers, P.A. — Orange City, Florida

Mid-Florida Hematology & Oncology Centers, P.A. is a clinical research site located in Orange City, Florida, United States 32763.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid-Florida Hematology & Oncology Centers, P.A. has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Lung Cancer, Non-small-cell Lung Carcinoma, Colorectal Cancer Metastatic.

Sponsors: Genentech, Inc., G1 Therapeutics, Inc., Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Florida Hematology & Oncology Centers, P.A.?

Mid-Florida Hematology & Oncology Centers, P.A. has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Florida Hematology & Oncology Centers, P.A. conducted?

Mid-Florida Hematology & Oncology Centers, P.A. has 4 clinical trials on record, with 1 currently active. Their work covers Lung Cancer, Non-small-cell Lung Carcinoma, Colorectal Cancer Metastatic.

Is Mid-Florida Hematology & Oncology Centers, P.A. accredited by Crixeo Health?

Mid-Florida Hematology & Oncology Centers, P.A. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Florida Hematology & Oncology Centers, P.A.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.